Peripheral effects induced in BALB/c mice infected with DENV by the intracerebral route

Virology

Volumn 489, Issue , 2016, Pages 95-107

  Oliveira, E R A ^a   Amorim, J F S ^a   Paes, M V ^a   Azevedo, A S ^a   Goncalves A J S ^a   Costa, S M ^a   Mantuano Barradas, M ^a   Povoa T F ^a   de Meis, J ^a   Basilio de Oliveira C A ^b   Nogueira, A C M A ^a   Alves, A M B ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

Author keywords

Central nervous system; Dengue; Immune response; Intracerebral infection; Mouse model

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN DAMAGE; BRAIN INFECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; HUMORAL IMMUNITY; INFECTION SENSITIVITY; LIVER INJURY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN; SYSTEMIC DISEASE; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS PARTICLE; ANIMAL; BAGG ALBINO MOUSE; BRAIN; DENGUE VIRUS; DISEASE MODEL; HUMAN; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMALS; CEREBRUM; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; VIRULENCE;

EID: 84952683563     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.12.006     Document Type: Article

References (57)

1. Amorim J.H., Porchia B.F., Balan A., Cavalcante R.C., da Costa S.M., de Barcelos Alves A.M., de Souza Ferreira L.C. Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein. J. Virol. Methods 2010, 167(2):186-192. 10.1016/j.jviromet.2010.04.003.
2. Araújo F.M., Araújo M.S., Nogueira R.M., Brilhante R.S., Oliveira D.N., Rocha M.F., Cordeiro R.A., Araújo R.M., Sidrim J.J. Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area. Neurology 2012, 78(10):736-742. 10.1212/WNL.0b013e31824b94e9.
3. Arima Y., Harada M., Kamimura D., Park J.H., Kawano F., Yull F.E., Kawamoto T., Iwakura Y., Betz U.A., Márquez G., Blackwell T.S., Ohira Y., Hirano T., Murakami M. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 2012, 148:447-457. 10.1016/j.cell.2012.01.022.
4. Azevedo A.S., Yamamura A.M., Freire M.S., Trindade G.F., Bonaldo M., Galler R., Alves A.M. DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III. PLoS One 2011, 6(7):e20528. 10.1371/journal.pone.0020528.
5. Basílio-de-Oliveira C.A., Aguiar G.R., Baldanza M.S., Barth O.M., Eyer-Silva W.A., et al. Pathologic study of a fatal case of dengue-3 virus infection in Rio de Janeiro. J. Infect. Dis. 2005, 9:341-347.
6. Berkowitz A.L., Raibagkar P., Pritt B.S., Mateen F.J. Neurologic manifestations of the neglected tropical diseases. J. Neurol. Sci. 2015, 349(1-2):20-32. 10.1016/j.jns.2015.01.001.
7. Bhamarapravati N., Tuchinda P., Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann. Trop. Med. Parasitol. 1967, 61(4):500-510.
8. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., Drake J.M., Brownstein J.S., Hoen A.G., Sankoh O., Myers M.F., George D.B., Jaenisch T., Wint G.R., Simmons C.P., Scott T.W., Farrar J.J., Hay S.I. The global distribution and burden of dengue. Nature 2013, 496(7446):504-507. 10.1038/nature12060.
9. Bordignon J., Probst C.M., Mosimann A.L., Pavoni D.P., Stella V., Buck G.A., Satproedprai N., Fawcett P., Zanata S.M., de Noronha L., Krieger M.A., Duarte Dos Santos C.N. Expression profile of interferon stimulated genes in central nervous system of mice infected with dengue virus type-1. Virology 2008, 377(2):319-329. 10.1016/j.virol.2008.04.033.
10. Burke T. Dengue haemorrhagic fever: a pathological study. Am. J. Trop. Med. Hyg. 1978, 62:682-692.
11. Carod-Artal F.J., Wichmann O., Farrar J., Gascón J. Neurological complications of dengue virus infection. Lancet Neurol. 2013, 12(9):906-919. 10.1016/S1474-4422(13)70150-9.
12. Chimelli L., Hahn M.D., Netto M.B., Ramos R.G., Dias M., Gray F. Dengue: neuropathological findings in 5 fatal cases from Brazil. Clin. Neuropathol. 1990, 9(3):157-162.
13. Chuansumrit A., Chaiyaratana W.2 Hemostatic derangement in dengue hemorrhagic fever. Thromb. Res. 2014, 133(1):10-16. 10.1016/j.thromres.2013.09.028.
14. Clements D.E., Coller B.A., Lieberman M.M., Ogata S., Wang G., Harada K.E., Putnak J.R., Ivy J.M., McDonell M., Bignami G.S., Peters I.D., Leung J., Weeks-Levy C., Nakano E.T., Humphreys T. Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys. Vaccine 2010, 28(15):2705-2715. 10.1016/j.vaccine.2010.01.022.
15. Costa S.M., Yorio A.P., Gonçalves A.J., Vidale M.M., Costa E.C., Mohana-Borges R., Motta M.A., Freire M.S., Alves A.M. Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines. PLoS One 2011, 6(10):e25685. 10.1371/journal.pone.0025685.
16. Couvelard A., Marianneau P., Bedel C., Drouet M.T., Vachon F., et al. Report a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum. Pathol. 1999, 30:1106-1110.
17. de Souza K.P., Silva E.G., de Oliveira Rocha E.S., Figueiredo L.B., de Almeida-Leite C.M., Arantes R.M., de Assis Silva Gomes J., Ferreira G.P., de Oliveira J.G., Kroon E.G., Campos M.A. Nitric oxide synthase expression correlates with death in an experimental mouse model of dengue with CNS involvement. Virol. J. 2013, 10:267. 10.1186/1743-422X-10-267.
18. Engelhardt B., Coisne C. Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS 2011, 8(1):4. 10.1186/2045-8118-8-4.
19. Erhardt W., Hebestedt A., Aschenbrenner G., Pichotka B., Blümel G. A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate. Res. Exp. Med. (Berl) 1984, 184(3):159-169.
20. França R.F., Zucoloto S., da Fonseca B.A. A BALB/c mouse model shows that liver involvement in dengue disease is immune-mediated. Exp. Mol. Pathol. 2010, 89(3):321-326. 10.1016/j.yexmp.2010.07.007.
21. Gubler D.J. The economic burden of dengue. Am. J. Trop. Med. Hyg. 2012, 86(5):743-744. 10.4269/ajtmh.2012.12-0157.
22. Hatterer E., Davoust N., Didier-Bazes M., Vuaillat C., Malcus C., Belin M.F., Nataf S. How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes. Blood 2006, 107:806-812.
23. Huerre M.R., Lan N.T., Marianneau P., Hue N.B., Khun H., et al. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamense children. Virchows Arch. 2001, 438:107-115.
24. Huy N.T., Van Giang T., Thuy D.H., Kikuchi M., Hien T.T., Zamora J., Hirayama K. Factors Associated with Dengue Shock Syndrome: A Systematic Review and Meta-Analysis. PLoS Negl. Trop. Dis. 2013, 7(9):e2412. 10.1371/journal.pntd.0002412.
25. Kamimura D., Yamada M., Harada M., Sabharwal L., Meng J., Bando H., Ogura H., Atsumi T., Arima Y., Murakami M. The gateway theory: bridging neural and immune interactions in the CNS. Front. Neurosci. 2013, 7:204. 10.3389/fnins.2013.00204.
26. Kho L.K., Sumarmo, Wulur H., Jahja E.C., Gubler D.J. Dengue hemorrhagic fever accompanied by encephalopathy in Jakarta. Southeast Asian J. Trop. Med. Public Health 1981, 12(1):83-86.
27. Koshy J.M., Joseph D.M., John M., Mani A., Malhotra N., Abraham G.M., Pandian J. Spectrum of neurological manifestations in dengue virus infection in Northwest India. Trop. Doct. 2012, 42(4):191-194. 10.1258/td.2012.120286.
28. Laman J.D., Weller R.O. Editorial: route by which monocytes leave the brain is revealed. J. Leukoc. Biol. 2012, 92(1):6-9. 10.1189/jlb.0212110.
29. Lin Y.L., Liao C.L., Chen L.K., Yeh C.T., Liu C.I., Ma S.H., Huang Y.Y., Huang Y.L., Kao C.L., King C.C. Study of dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 1998, 72(12):9729-9737.
30. Lum L.C., Lam S.K., Choy Y.S., George R., Harun F. Dengue encephalitis: a true entity?. Am. J. Trop. Med. Hyg. 1996, 54:256-259.
31. Martina B.E., Koraka P., Osterhaus A.D. Dengue virus pathogenesis: an integrated view. Clin. Microbiol. Rev. 2009, 22(4):564-581. 10.1128/CMR.00035-09.
32. Miagostovich M.P., Ramos R.G., Nicol A.F., Nogueira R.M., Cuzzi-Maya T., Oliveira A.V., Marchevsky R.S., Mesquita R.P., Schtzamyr H.G. Retrospective study on dengue fatal cases. Clin. Neuropathol. 1997, 16(4):204-208.
33. Misra U.K., Kalita J. Seizures in encephalitis: predictors and outcomes. Seizure 2009, 18(8):583-587. 10.1016/j.seizure.2009.06.003.
34. Nguyen T.L., Nguyen T.H., Tieu N.T. The impact of dengue haemorrhagic fever on liver function. Res. Virol. 1997, 148(4):273-277.
35. Paes M.V., Lenzi H.L., Nogueira A.C., Nuovo G.J., Pinhão A.T., Mota E.M., Basílio-de-Oliveira C.A., Schatzmayr H., Barth O.M., Alves A.M. Hepatic damage associated with dengue-2 virus replication in liver cells of BALB/c mice. Lab. Invest. 2009, 89(10):1140-1151. 10.1038/labinvest.2009.83.
36. Paes M.V., Pinhão A.T., Barreto D.F., Costa S.M., Oliveira M.P., Nogueira A.C., Takiya C.M., Farias-Filho J.C., Schatzmayr H.G., Alves A.M., Barth O.M. Liver injury and viremia in mice infected with dengue-2 virus. Virology 2005, 338(2):236-246.
37. Patey O., Ollivaud L., Breuil J., Lafaix C. Unusual neurologic manifestations occurring during dengue fever infection. Am. J. Trop. Med. Hyg. 1993, 48:793-802.
38. Plummer E.M., Shresta S. Mouse models for dengue vaccine and antivirals. J. Immunol. Methods 2014, 410:34-38. 10.1016/j.jim.2014.01.001.
39. Porter K.R., Kochel T.J., Wu S.J., Raviprakash K., Phillips I., Hayes C.G. Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses. Arch. Virol. 1998, 143(5):997-1003.
40. Póvoa T.F., Alves A.M., Oliveira C.A., Nuovo G.J., Chagas V.L., Paes M.V. The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One 2014, 9(4):e83386. 10.1371/journal.pone.0083386.
41. Rothman A.L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 2011, 11(8):532-543. 10.1038/nri3014.
42. Row D., Weinstein P., Murray-Smith S. Dengue fever with encephalopathy in Australia. Am. J. Trop. Med. Hyg. 1996, 54(3):253-255.
43. Sabin A.B., Schlesinger R.W. Production of immunity to dengue with virus modified by propagation in mice. Science 1945, 101(2634):640-642.
44. Sarathy V.V., White M., Li L., Gorder S.R., Pyles R.B., Campbell G.A., Milligan G.N., Bourne N., Barrett A.D. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. J. Virol. 2015, 89(2):1254-1266. 10.1128/JVI.01320-14.
45. Shi S.R., Shi Y., Taylor C.R. Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades. J. Histochem. Cytochem. 2011, 59(1):13-32. 10.1369/jhc.2010.957191.
46. Shresta S., Kyle J.L., Robert Beatty P., Harris E. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 2004, 319(2):262-273.
47. Soares C., Puccioni-Sohler M. Diagnosis criteria of dengue encephalitis. Arq. Neuropsiquiatr. 2013, 72(3):263.
48. Souza L.J., Alves J.G., Nogueira R.M., Gicovate Neto C., Bastos D.A., Siqueira E.W., Souto Filho J.T., Cezário Tde A., Soares C.E., Carneiro Rda C. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz. J. Infect. Dis. 2004, 8(2):156-163.
49. Sumarmo W.H., Jahja E., Gubler D.J., Suharyono W., Sorensen K. Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull. World Health Organ. 1983, 61(4):693-701.
50. Sumarmo W.H., Jahja E., Gubler D.J., Sutomenggolo T.S., Saroso J.S. Encephalopathy associated with dengue infection. Lancet 1978, 1(8061):449-450.
51. Sung J.M., Lee C.K., Wu-Hsieh B.A. Intrahepatic infiltrating NK and CD8 T cells cause liver cell death in different phases of dengue virus infection. PLoS One 2012, 7(9):e46292. 10.1371/journal.pone.0046292.
52. Valdés I., Bernardo L., Gil L., Pavón A., Lazo L., López C., Romero Y., Menendez I., Falcón V., Betancourt L., Martín J., Chinea G., Silva R., Guzmán M.G., Guillén G., Hermida L. A novel fusion protein domain III-capsid from dengue-2 in a highly aggregated form induces a functional immune response and protection in mice. Virology 2009, 394(2):249-258. 10.1016/j.virol.2009.08.029.
53. Velandia-Romero M.L., Acosta-Losada O., Castellanos J.E. In vivo infection by a neuroinvasive neurovirulent dengue virus. J. Neurovirol. 2012, 18(5):374-387. 10.1007/s13365-012-0117-y.
54. Weller R.O., Galea I., Carare R.O., Minagar A. Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis. Pathophysiology 2010, 17(4):295-306. 10.1016/j.pathophys.2009.10.007.
55. World Health Organization, 2013. WHO Expert Committee on Biological Standardization. World Health Organ Tech Rep Ser, 979, 1-366 back cover.
56. Yauch L.E., Shresta S. Mouse models of dengue virus infection and disease. Antivir. Res. 2008, 80(2):87-93. 10.1016/j.antiviral.2008.06.010.
57. Zellweger R.M., Miller R., Eddy W.E., White L.J., Johnston R.E., Shresta S. Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. PLoS Pathog. 2013, 9(10):e1003723. 10.1371/journal.ppat.1003723.